Submitted by wrhollin t3_yfothk in askscience
Hello all! Bit of background: I'm a physical chemist by training, and did my doctoral work on self-assembly in conjugated polyelectrolytes. In that field there are open questions about how things like temperature, pH, salt content drive and control self-assembly and processes like liquid-liquid phase separation. I recently came across this article discussing liquid-liquid phase separation of Tau. I have very marginal knowledge of the state of Alzheimer's research and whether the various hypotheses regarding plaque aggregation are causal or symptomatic. So I'd like to know more about whether the CNS of folks with Alzheimer's varies significantly in its pH and electrolytic balance vs a normative sample of CNS.
For the record: I'm no longer in academia (although I still have journal access) and my industry is semiconductors, not biomedical. So I'm not fishing for competitive advantage in this field.
Cheers, and thank you.
FlowersForAlgerVon t1_iu4z5bb wrote
I can weigh in since I'm in the field. You don't generally see pH differences in the cerebral spinal fluid, our body does a pretty good job at regulating it. You DO see differences in pH in the cell, i.e. lysosome is about pH 4.6 and cytosol is about pH 7.2. Tau and beta amyloid protein do experience a range of pH environments. One of the hypothesis for the spread of tau is through the process of endocytosis, wherein a neuron that contains tau tangles may die and release the tau, then an adjacent neuron creates a pouch that internalizes outside contents (including tau proteins). This pouch becomes an endosome which becomes acidic in nature.
On the topic of the causation or symptom, it is unclear, but we do know there is a positive feedback loop. In clinic trials, we've gone after Abeta plaques, but these drugs show limited efficacy (Aducanumab is an FDA approved antibody that clears Abeta plaques, but again limited efficacy).
​
In terms of CSF tests, there are some biomarkers being looked at right now that include soluble Abeta oligomers, hyperphosphorylated tau, even certain enzymes. Though the way they diagnose AD generally is by ruling out other dementias, and then brain scans.